Rabusertib T6084
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Rabusertib is an inhibitor of the cell cycle checkpoint kinase 2 (chk2) with potential chemopotentiating activity. Rabusertib has been used in trials studying the treatment of Cancer, Solid Tumors, Advanced Cancer, Pancreatic Neoplasms, and Non-Small Cell
CAS nr:
911222-45-2
Purity:
98%
Molecular Weight:
436,3
SMILES:
Cc1cc(c(cc1Br)NC(=O)Nc1ncc(nc1)C)OC[C@@H]1CNCCO1
Formula:
C18H22BrN5O3
Pathway:
Cell Cycle/Checkpoint,Autophagy,PI3K/Akt/mTOR signaling
Target:
Chk,Autophagy,PDK
